Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial

Authors

Jonathan Kentley (ORCID: https://orcid.org/0000-0002-7109-6199)
Andre Khoo (ORCID: https://orcid.org/0000-0002-6734-1438)
Jean Y. Tang (ORCID: https://orcid.org/0000-0002-5510-6502)
Catherine Harwood (ORCID: https://orcid.org/0000-0002-1375-0965)
Alix Alderman
Zeeshaan Hasan
Jason Thomson (ORCID: https://orcid.org/0000-0002-6644-0979)
John T. Lear (ORCID: https://orcid.org/0000-0002-2969-9922)
Gerd G. Kochendoerfer (ORCID: https://orcid.org/0009-0005-2045-4151)
Mark S. deSouza
Ervin H. Epstein

Institutions

Queen Mary University of London (GB)
Barts Health NHS Trust (GB)
Manchester Academic Health Science Centre (GB)
Royal London Hospital (GB)
Manchester Royal Infirmary (GB)
University of Manchester (GB)
PellePharm (United States) (US)
Stanford University (US)

Publication Details

Journal: British Journal of Dermatology
Published: 2024-11-15
DOI: https://doi.org/10.1093/bjd/ljae444
Citations: 6
Primary Topic: Hedgehog Signaling Pathway Studies
Type: article
Field-Weighted Citation Impact: 1.40

Funders

Medical Research Council

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial

Jonathan Kentley, Andre Khoo, Jean Y. Tang, Catherine Harwood et al.

Nov 15, 2024

6 citations

British Journal of Dermatology

Hedgehog Signaling Pathway Studies

1.40

article

Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial

Jonathan Kentley, Andre Khoo, Jean Y. Tang, Catherine Harwood, Alix Alderman, Zeeshaan Hasan, Jason Thomson, John T. Lear, Gerd G. Kochendoerfer, Mark S. deSouza, Ervin H. Epstein

November 15, 2024article en

6 citations

Abstract

No abstract available for this paper.

British Journal of DermatologyVol. 192(4)

Queen Mary University of London (GB), Barts Health NHS Trust (GB), Manchester Academic Health Science Centre (GB), Royal London Hospital (GB), Manchester Royal Infirmary (GB), University of Manchester (GB), PellePharm (United States) (US), Stanford University (US)

Medical Research Council

Good health and well-being

Openalex Percentile: Top 18%

Hedgehog Signaling Pathway Studies

1.40

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial — Jonathan Kentley, Andre Khoo, et al. · British Journal of Dermatology (2024) | TGRS Research Map | TGRS